Steven R. Smith, MD, AdventHealth’s chief scientific officer discussed AdventHealth Translational Research Institute’s decade of discovery in Central Florida on a recent webinar with the Florida Medical Association. “I’ve never been more optimistic about the state of biomedical science and medical science than I am right now,” Smith said.
Smith, who has overseen TRI since its inception, explained the medical research currently taking place, and where the Translational Research Institute (TRI), is headed. “We feel an obligation to conduct research. We want to learn from our patients so we can improve the care we provide them,” Smith said.
TRI’s mission is to extend and improve the quality of lives by conducting world-class, innovative translational research that leads to discoveries and ultimately cures for obesity, diabetes and cardiovascular diseases. Over the past 10 years, TRI researchers have conducted more than 200 studies and produced more than 350 peer reviewed, published works that have helped to advance medicine. Smith explained, “To define it simply, translation is bedside to bench. We’re going to study human biology with cells, tissue and DNA and then we’re going to relate that back to the human condition.”
During the conversation, Smith spoke about the importance of collaboration and innovation in research and answered questions from viewers.
You can watch the webinar by clicking play below:
Before the webinar, FMA invited Smith to talk about why TRI is unique, its milestones and what excited him most about the work being done there. Click here to read that article.
6 items. To interact with these items, press Control-Option-Shift-Right Arrow.
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism and co-authored by Dr. Corbin introduces a metagenomics-powered approach to...
Mayor Demings, AdventHealth on bridging health care gaps
Discover what’s being accomplished in Central Florida to bridge the health gap with Orange County Mayor Jerry Demings and AdventHealth’s Dr. Alric Simmonds.
Transforming lives of stroke survivors: AdventHealth, Orlando Neurosurgery first in nation to perform 50 Vivistim implant cases
Breakthrough device offers new hope for stroke survivors struggling with rehabilitation following ischemic stroke
AdventHealth Inflammatory Bowel Disease Clinic Adds Intestinal Ultrasound to Help Evaluate and Guide Treatment
Jennifer Seminerio, MD, recently became one of the first in Florida to use intestinal ultrasound (IUS) to help assess and manage treatment of patients with inflammatory bowel disease (IBD). A non...
AdventHealth Daytona Beach Surgeon First in Florida to Perform Robotic-assisted Convergent Hybrid Ablation Procedure
The Convergent Hybrid Ablation procedure has been gaining acceptance as an effective treatment option for long-standing persistent atrial fibrillation (AFib) since the CONVERGE trial data published in...